ANIK - Anika Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue113,420103,37992,999105,595
Cost of Revenue27,36424,02721,05320,930
Gross Profit86,05679,35271,94684,665
Operating Expenses
Research Development18,78710,7328,2908,144
Selling General and Administrative21,54018,01314,82515,074
Non Recurring----
Others----
Total Operating Expenses67,69152,77244,16844,148
Operating Income or Loss45,72950,60748,83161,447
Income from Continuing Operations
Total Other Income/Expenses Net473263-57758
Earnings Before Interest and Taxes45,72950,60748,83161,447
Interest Expense----
Income Before Tax46,20250,87048,25461,505
Income Tax Expense14,38618,32317,49623,186
Minority Interest----
Net Income From Continuing Ops31,81632,54730,75838,319
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income31,81632,54730,75838,319
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares31,81632,54730,75838,319